Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 4Phase NA 2Phase 2/3 2Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Rectal Neoplasms 4Colorectal Neoplasms 4Sarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Astrocytoma 2Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Carcinoma In Situ 1Brain Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 31Fluorouracil 31Leucovorin 29Irinotecan 23Cetuximab 20Bevacizumab 16Capecitabine 13Gemcitabine 11pembrolizumab 8Folfox protocol 7Cisplatin 7Carboplatin 7Paclitaxel 6Nivolumab 6Cyclophosphamide 6trifluridine tipiracil drug combination 5cediranib 5Erlotinib Hydrochloride 5adagrasib 4Ipilimumab 4IFL protocol 4Floxuridine 4Bortezomib 4veliparib 3trametinib 3sargramostim 3poly ICLC 3binimetinib 3Trifluridine 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Colonic Neoplasms × Neoadjuvant Therapy × Clear all
NCT00005616 2013-06-19

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
12 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡